This Week on NeurologyLive® — December 4, 2023
Here's some of what is coming soon to NeurologyLive® this week.
Phase 2 Trial of Alzheimer Psychosis Initiated, FDA Declines to Lift Hold on ENTR-601-44, Levetiracetam and Clobazam With Safety Warnings
Neurology News Network for the week ending December 1, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — December 1, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 1, 2023.
This Week on NeurologyLive® — November 27, 2023
FDA Grants BrainStorm Meeting for NurOwn, Gene Therapy Study of AB-1005 Underway, VISION Trial to Test DBS Enhancement in PD
Neurology News Network for the week ending November 25, 2023. [WATCH TIME: 4 minutes
NeurologyLive® Friday 5 — November 24, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 24, 2023.
This Week on NeurologyLive® — November 20, 2023
Valbenazine Shines in Open-Label Extension, FDA Grants Breakthrough Designation to NfL Test, Tocilizumab Effective in NMOSD
Neurology News Network for the week ending November 18, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — November 17, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 17, 2023.
This Week on NeurologyLive® — November 13, 2023
FDA Clears Modius Sleep Device, NDA Accepted for SPN-830, Zilucoplan Improves Myasthenic Fatigue
Neurology News Network for the week ending November 11, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — November 10, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 10, 2023.
This Week on NeurologyLive® — November 6, 2023
Migraine Preventive Prescription Trends, TAK-861 Phase 1 Study in Narcolepsy, Simufilam Not Associated With ARIA-E
Neurology News Network for the week ending November 4, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — November 3, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 3, 2023.
This Week on NeurologyLive® — October 30, 2023
FDA Approves Vamorolone for DMD, Tau Agent BIIB080 Shows Promising Results, Subcutaneous Lecanemab More Effective in Amyloid Removal
Neurology News Network for the week ending October 28, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — October 27, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 27, 2023.
This Week on NeurologyLive® — October 23, 2023
Solanezumab Fails A4 Alzheimer Study, FDA Lifts Hold on FREEDOM-DM1 Trial, CMS Announces Coverages of PET Amyloid-ß Imaging
Neurology News Network for the week ending October 21, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 20, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 20, 2023.
This Week on NeurologyLive® — October 16 2023
FDA Hands CRL to Patisiran, GBA1 Parkinson Trial Initiated, Levetiracetam Effective as First-Line Treatment in IGE Syndromes
Neurology News Network for the week ending October 14, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 13, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 13, 2023.
This Week on NeurologyLive® — October 9 2023
FDA Clears High Dose Cohort of CTI-1601, SOMNUM AI Device Approved, Intracranial Pressure Monitoring and TBI
Neurology News Network for the week ending October 7, 2023. [WATCH TIME: 3 minutes]
NeurologyLive® Friday 5 — October 6, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 6, 2023.
This Week on NeurologyLive® — October 2, 2023
AdComm Committee Downvotes NurOwn, ADELY01 Cleared for Trials, Axsome Pushes Back SYMPHONY Trial
Neurology News Network for the week ending September 30, 2023. [WATCH TIME: 4 minutes]
NeurologyLive® Friday 5 — September 29, 2023
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending September 29, 2023.